Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S A Casey

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Journal of the American College of Cardiology|May 20, 1999
Clinical profile of hypertrophic cardiomyopathy identified de novo in rural communitiesB J Maron, R Mathenge, S A Casey, et al.
Circulation|November 21, 2001
Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathyI Olivotto, F Cecchi, S A Casey, et al.
JAMA|February 24, 1999
Clinical course of hypertrophic cardiomyopathy in a regional United States cohortB J Maron, S A Casey, L C Poliac, et al.
Journal of the American College of Cardiology|August 14, 2001
Development of left ventricular hypertrophy in adults in hypertrophic cardiomyopathy caused by cardiac myosin-binding protein C gene mutationsB J Maron, H Niimura, S A Casey, et al.
Circulation|August 23, 2000
Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large non-referral-based patient populationB J Maron, I Olivotto, P Spirito, et al.
The American Journal of Cardiology|January 4, 2001
Assessment of QT dispersion as a prognostic marker for sudden death in a regional nonreferred hypertrophic cardiomyopathy cohortB J Maron, M J Leyhe, S A Casey, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Journal of the American College of Cardiology|May 20, 1999
Clinical profile of hypertrophic cardiomyopathy identified de novo in rural communitiesB J Maron, R Mathenge, S A Casey, et al.
Circulation|November 21, 2001
Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathyI Olivotto, F Cecchi, S A Casey, et al.
JAMA|February 24, 1999
Clinical course of hypertrophic cardiomyopathy in a regional United States cohortB J Maron, S A Casey, L C Poliac, et al.
Journal of the American College of Cardiology|August 14, 2001
Development of left ventricular hypertrophy in adults in hypertrophic cardiomyopathy caused by cardiac myosin-binding protein C gene mutationsB J Maron, H Niimura, S A Casey, et al.
Circulation|August 23, 2000
Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large non-referral-based patient populationB J Maron, I Olivotto, P Spirito, et al.
The American Journal of Cardiology|January 4, 2001
Assessment of QT dispersion as a prognostic marker for sudden death in a regional nonreferred hypertrophic cardiomyopathy cohortB J Maron, M J Leyhe, S A Casey, et al.
Pageof 1